{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:32:52Z","timestamp":1765546372425},"reference-count":48,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Med Report"],"DOI":"10.3892\/mmr.2018.9739","type":"journal-article","created":{"date-parts":[[2018,12,13]],"date-time":"2018-12-13T11:47:29Z","timestamp":1544701649000},"source":"Crossref","is-referenced-by-count":7,"title":["Novel adeno\u2011associated virus\u2011based genetic vaccines encoding hepatitis C virus E2 glycoprotein elicit humoral immune responses in mice"],"prefix":"10.3892","author":[{"given":"Fengqin","family":"Zhu","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, Shandong 272000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yibo","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, Shandong 272000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, Shandong 272000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyang","family":"Qu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, Shandong 272000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hairong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, Shandong 272000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingling","family":"Niu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, Shandong 272000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honglu","family":"Xue","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, Shandong 272000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dehuai","family":"Jing","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, Shandong 272000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heng","family":"He","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, Shandong 272000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2018,12,11]]},"reference":[{"key":"key20200713231643_b1-mmr-19-02-1016","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1093\/nsr\/nwv040","article-title":"Hepatitis C virus vaccine development: Old challenges and new opportunities","volume":"2","author":"Li","year":"2015","journal-title":"Natl Sci Rev"},{"key":"key20200713231643_b2-mmr-19-02-1016","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1053\/j.gastro.2016.04.003","article-title":"Hepatitis C virus resistance to direct-acting antiviral drugs in interferonfree regimens","volume":"151","author":"Pawlotsky","year":"2016","journal-title":"Gastroenterology"},{"key":"key20200713231643_b3-mmr-19-02-1016","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1056\/NEJMoa1306218","article-title":"Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection","volume":"370","author":"Gardiner","year":"2014","journal-title":"N Engl J Med"},{"key":"key20200713231643_b4-mmr-19-02-1016","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/hep.27259","article-title":"Global distribution and prevalence of hepatitis C virus genotypes","volume":"61","author":"Humphreys","year":"2015","journal-title":"Hepatology"},{"key":"key20200713231643_b5-mmr-19-02-1016","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1053\/jhep.2001.24371","article-title":"Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection","volume":"33","author":"Bassett","year":"2001","journal-title":"Hepatology"},{"key":"key20200713231643_b6-mmr-19-02-1016","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1128\/JVI.78.1.187-196.2004","article-title":"Control of heterologous hepatitis C virus infection in chimpanzees is associated with the quality of vaccine-induced peripheral T-helper immune response","volume":"78","author":"Rollier","year":"2004","journal-title":"J Virol"},{"key":"key20200713231643_b7-mmr-19-02-1016","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1002\/hep.27013","article-title":"Clearance of hepatitis C infection is associated with the early appearance of broad neutralizing antibody responses","volume":"59","author":"Osburn","year":"2014","journal-title":"Hepatology"},{"key":"key20200713231643_b8-mmr-19-02-1016","doi-asserted-by":"publisher","first-page":"6367","DOI":"10.1016\/j.vaccine.2010.06.084","article-title":"Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults","volume":"28","author":"Frey","year":"2010","journal-title":"Vaccine"},{"key":"key20200713231643_b9-mmr-19-02-1016","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1086\/655902","article-title":"Characterization of antibodies induced by vaccination with hepatitis C virus envelope glycoproteins","volume":"202","author":"Ray","year":"2010","journal-title":"J Infect Dis"},{"key":"key20200713231643_b10-mmr-19-02-1016","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1126\/science.1243876","article-title":"Hepatitis C virus E2 envelope glycoprotein core structure","volume":"342","author":"Kong","year":"2013","journal-title":"Science"},{"key":"key20200713231643_b11-mmr-19-02-1016","doi-asserted-by":"publisher","first-page":"7418","DOI":"10.1073\/pnas.1305306110","article-title":"Structural evidence for a bifurcated mode of action in the antibody-mediated neutralization of hepatitis C virus","volume":"110","author":"Deng","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200713231643_b12-mmr-19-02-1016","doi-asserted-by":"publisher","first-page":"12768","DOI":"10.1073\/pnas.1609780113","article-title":"Structural flexibility at a major conserved antibody target on hepatitis C virus E2 antigen","volume":"113","author":"Kong","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200713231643_b13-mmr-19-02-1016","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1099\/jgv.0.000735","article-title":"Identification of a novel epitope in the C terminus of hepatitis C virus-E2 protein that induces potent and cross-reactive neutralizing antibodies","volume":"98","author":"Das","year":"2017","journal-title":"J Gen Virol"},{"key":"key20200713231643_b14-mmr-19-02-1016","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/hep.510250234","article-title":"A specific antibody response to HCV E2 elicited in mice by intramuscular inoculation of plasmid DNA containing coding sequences for E2","volume":"25","author":"Tedeschi","year":"1997","journal-title":"Hepatology"},{"key":"key20200713231643_b15-mmr-19-02-1016","doi-asserted-by":"publisher","first-page":"94ra71","DOI":"10.1126\/scitranslmed.3002330","article-title":"A prime-boost strategy using virus-like particles pseudotyped for HCV proteins triggers broadly neutralizing antibodies in macaques","volume":"3","author":"Garrone","year":"2011","journal-title":"Sci Transl Med"},{"key":"key20200713231643_b16-mmr-19-02-1016","doi-asserted-by":"publisher","first-page":"10486","DOI":"10.1128\/JVI.01462-16","article-title":"Altered glycosylation patterns increase immunogenicity of a subunit hepatitis C virus vaccine, inducing neutralizing antibodies which confer protection in mice","volume":"90","author":"Li","year":"2016","journal-title":"J Virol"},{"key":"key20200713231643_b17-mmr-19-02-1016","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1093\/infdis\/jix180","article-title":"Immunization with a subunit hepatitis C virus vaccine elicits pan-genotypic neutralizing antibodies and intrahepatic T-cell responses in nonhuman primates","volume":"215","author":"Li","year":"2017","journal-title":"J Infect Dis"},{"key":"key20200713231643_b18-mmr-19-02-1016","article-title":"A trivalent HCV vaccine elicits broad and synergistic polyclonal antibody response in mice and rhesus monkey","author":"Wang","year":"2017","journal-title":"Gut"},{"key":"key20200713231643_b19-mmr-19-02-1016","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nrmicro2240","article-title":"Viruses as vaccine vectors for infectious diseases and cancer","volume":"8","author":"Draper","year":"2010","journal-title":"Nat Rev Microbiol"},{"key":"key20200713231643_b20-mmr-19-02-1016","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1080\/21645515.2017.1419108","article-title":"Development of novel vaccine vectors: Chimpanzee adenoviral vectors","volume":"14","author":"Guo","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"key20200713231643_b21-mmr-19-02-1016","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2174\/1566523217666170314141931","article-title":"The adeno-associated virus-A safe and promising vehicle for liverspecific gene therapy of inherited and non-inherited disorders","volume":"17","author":"Mak","year":"2017","journal-title":"Curr Gene Ther"},{"key":"key20200713231643_b22-mmr-19-02-1016","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.3892\/mmr.2017.6235","article-title":"Recombinant adeno-associated virus serotype 9 in a mouse model of atherosclerosis: Determination of the optimal expression time in vivo","volume":"15","author":"Chen","year":"2017","journal-title":"Mol Med Rep"},{"key":"key20200713231643_b23-mmr-19-02-1016","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.ymthe.2016.11.017","article-title":"rAAV8-733-mediated gene transfer of CHIP\/Stub-1 prevents hippocampal neuronal death in experimental brain ischemia","volume":"25","author":"Cabral-Miranda","year":"2017","journal-title":"Mol Ther"},{"key":"key20200713231643_b24-mmr-19-02-1016","doi-asserted-by":"crossref","first-page":"7960","DOI":"10.1128\/JVI.71.10.7960-7962.1997","article-title":"Genetic immunization with adeno-associated virus vectors expressing herpes simplex virus type 2 glycoproteins B and D","volume":"71","author":"Manning","year":"1997","journal-title":"J Virol"},{"key":"key20200713231643_b25-mmr-19-02-1016","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1128\/JVI.80.6.2621-2630.2006","article-title":"Intranasal vaccination with recombinant adeno-associated virus type 5 against human papillomavirus type 16 L1","volume":"80","author":"Kuck","year":"2006","journal-title":"J Virol"},{"key":"key20200713231643_b26-mmr-19-02-1016","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.3851\/IMP1469","article-title":"Combined prophylactic and therapeutic intranasal vaccination against human papillomavirus type-16 using different adeno-associated virus serotype vectors","volume":"14","author":"Nieto","year":"2009","journal-title":"Antivir Ther"},{"key":"key20200713231643_b27-mmr-19-02-1016","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1093\/infdis\/jis699","article-title":"Protection against henipavirus infection by use of recombinant adeno-associated virus-vector vaccines","volume":"207","author":"Ploquin","year":"2013","journal-title":"J Infect Dis"},{"key":"key20200713231643_b28-mmr-19-02-1016","doi-asserted-by":"publisher","first-page":"11840","DOI":"10.1128\/JVI.01253-07","article-title":"Vaccines based on novel adeno-associated virus vectors elicit aberrant CD8+ T-cell responses in mice","volume":"8","author":"Lin","year":"2007","journal-title":"J Virol"},{"key":"key20200713231643_b29-mmr-19-02-1016","first-page":"3958","article-title":"Recombinant adeno-associated virus vectors induce functionally impaired transgene product-specific CD8+ T cells in mice","volume":"117","author":"Lin","year":"2007","journal-title":"J Clin Invest"},{"key":"key20200713231643_b30-mmr-19-02-1016","doi-asserted-by":"publisher","first-page":"31912","DOI":"10.1038\/srep31912","article-title":"AAV8-mediated angiotensin-converting enzyme 2 gene delivery prevents experimental autoimmune uveitis by regulating MAPK, NF-\u03baB and STAT3 pathways","volume":"6","author":"Qiu","year":"2016","journal-title":"Sci Rep"},{"key":"key20200713231643_b31-mmr-19-02-1016","doi-asserted-by":"publisher","first-page":"12738","DOI":"10.1128\/JVI.01441-09","article-title":"A new genetic vaccine platform based on an adeno-associated virus isolated from a rhesus macaque","volume":"83","author":"Lin","year":"2009","journal-title":"J Virol"},{"key":"key20200713231643_b32-mmr-19-02-1016","doi-asserted-by":"publisher","first-page":"6051","DOI":"10.4049\/jimmunol.0803965","article-title":"Adeno-associated virus capsid structure drives CD4-dependent CD8+ T cell response to vector encoded proteins","volume":"182","author":"Mays","year":"2009","journal-title":"J Immunol"},{"key":"key20200713231643_b33-mmr-19-02-1016","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.micinf.2012.05.002","article-title":"Novel AAV-based genetic vaccines encoding truncated dengue virus envelope proteins elicit humoral immune responses in mice","volume":"14","author":"Li","year":"2012","journal-title":"Microbes Infect"},{"key":"key20200713231643_b34-mmr-19-02-1016","doi-asserted-by":"publisher","first-page":"e0142349","DOI":"10.1371\/journal.pone.0142349","article-title":"A novel adeno-associated virus-based genetic vaccine encoding the hepatitis C virus NS3\/4 protein exhibits immunogenic properties in mice superior to those of an NS3-protein-based vaccine","volume":"10","author":"Zhu","year":"2015","journal-title":"PLoS One"},{"key":"key20200713231643_b35-mmr-19-02-1016","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1128\/JVI.72.3.2224-2232.1998","article-title":"Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus","volume":"72","author":"Xiao","year":"1998","journal-title":"J Virol"},{"key":"key20200713231643_b36-mmr-19-02-1016","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.1182\/blood-2004-10-3867","article-title":"Sustained correction of disease in naive and AAV2-pretreated hemophilia B dogs: AAV2\/8-mediated, liver-directed gene therapy","volume":"105","author":"Wang","year":"2005","journal-title":"Blood"},{"key":"key20200713231643_b37-mmr-19-02-1016","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/978-1-59745-394-3_32","article-title":"Detection of neutralizing antibodies with HCV pseudoparticles (HCVpp)","volume":"510","author":"Dreux","year":"2009","journal-title":"Methods Mol Biol"},{"key":"key20200713231643_b38-mmr-19-02-1016","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1186\/1743-422X-8-506","article-title":"Effect of route of delivery on heterologous protection against HCV induced by an adenovirus vector carrying HCV structural genes","volume":"8","author":"Guan","year":"2011","journal-title":"Virol J"},{"key":"key20200713231643_b39-mmr-19-02-1016","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1517\/13543776.2012.673589","article-title":"Advances in hepatitis C virus vaccines, part two: Advances in hepatitis C virus vaccine formulations and modalities","volume":"22","author":"Roohvand","year":"2012","journal-title":"Expert Opin Ther Pat"},{"key":"key20200713231643_b40-mmr-19-02-1016","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/nm.3183","article-title":"Current progress in development of hepatitis C virus vaccines","volume":"19","author":"Liang","year":"2013","journal-title":"Nat Med"},{"key":"key20200713231643_b41-mmr-19-02-1016","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/gt.2016.55","article-title":"T- and B-cell responses to multivalent prime-boost DNA and viral vectored vaccine combinations against hepatitis C virus in non-human primates","volume":"23","author":"Rollier","year":"2016","journal-title":"Gene Ther"},{"key":"key20200713231643_b42-mmr-19-02-1016","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.vaccine.2017.10.079","article-title":"The generation of a simian adenoviral vectored HCV vaccine encoding genetically conserved gene segments to target multiple HCV genotypes","volume":"36","author":"von Delft","year":"2018","journal-title":"Vaccine"},{"key":"key20200713231643_b43-mmr-19-02-1016","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/imr.12478","article-title":"Antibody gene transfer with adeno-associated viral vectors as a method for HIV prevention","volume":"275","author":"Brady","year":"2017","journal-title":"Immunol Rev"},{"key":"key20200713231643_b44-mmr-19-02-1016","doi-asserted-by":"publisher","first-page":"11854","DOI":"10.1073\/pnas.182412299","article-title":"Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy","volume":"99","author":"Gao","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200713231643_b45-mmr-19-02-1016","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1128\/JVI.02190-14","article-title":"Structural flexibility of a conserved antigenic region in hepatitis C virus glycoprotein E2 recognized by broadly neutralizing antibodies","volume":"89","author":"Meola","year":"2015","journal-title":"J Virol"},{"key":"key20200713231643_b46-mmr-19-02-1016","doi-asserted-by":"publisher","first-page":"e00382","DOI":"10.1128\/mBio.00382-17","article-title":"Conformational flexibility in the immunoglobulin-like domain of the hepatitis C virus glycoprotein E2","volume":"8","author":"Vasiliauskaite","year":"2017","journal-title":"MBio"},{"key":"key20200713231643_b47-mmr-19-02-1016","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1159\/000481561","article-title":"Genotype distribution and molecular epidemiology of hepatitis C virus in Guangzhou, China: Predominance of genotype 1b and increasing incidence of genotype 6a","volume":"43","author":"Yuan","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"key20200713231643_b48-mmr-19-02-1016","doi-asserted-by":"publisher","first-page":"e59776","DOI":"10.1371\/journal.pone.0059776","article-title":"A hepatitis C virus (HCV) vaccine comprising envelope glycoproteins gpE1\/gpE2 derived from a single isolate elicits broad cross-genotype neutralizing antibodies in humans","volume":"8","author":"Law","year":"2013","journal-title":"PLoS One"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T23:52:12Z","timestamp":1594684332000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mmr.2018.9739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,11]]},"references-count":48,"URL":"https:\/\/doi.org\/10.3892\/mmr.2018.9739","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,11]]}}}